News & Updates

Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders

Encellin has developed an Encapsulated Cell Replacement Therapy (EnCRT) to isolate therapeutic cells from the body’s immune system, to help...

Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergence™ AI Platform

Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, today announced a multi-year agreement with Eli Lilly...

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development

The funds raised in this round will support the further clinical development of Siolta’s lead product, STMC-103H, a defined-consortia Live...

X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity

The funds will be used to advance development of the drug candidate HOPO-101 through registrational studies as a medical countermeasure...

GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology

The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s...

Argenx signs $1.5B pact to turn Unnatural Products’ macrocyclic peptides to ‘undruggable’ targets

Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Californian...

Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test

Using precise measurements of a patient’s immune response, TriVerity combines highly accurate bacterial-viral infection scoring with an all-cause illness severity...

AstraZeneca, Algen Biotechnologies pen $555M AI pact for immunology targets